Zobrazeno 1 - 10
of 159
pro vyhledávání: '"Nancy Martin"'
COMPUTER ETHICS OF AMERICAN AND EUROPEAN INFORMATION TECHNOLOGY STUDENTS: A CROSS-CULTURAL COMPARISO
Autor:
Nancy Martin, Belle Woodward
Publikováno v:
Issues in Information Systems, Vol 12, Iss 1, Pp 78-87 (2011)
Externí odkaz:
https://doaj.org/article/ecad260b4dea40ebb9b24e22db5a0085
Autor:
Nancy Martin, David Green
Publikováno v:
Issues in Information Systems, Vol 11, Iss 1, Pp 640-643 (2010)
Externí odkaz:
https://doaj.org/article/b729f9bd8d9f402089662b329ac87b6e
Autor:
Nancy Martin
Publikováno v:
Issues in Information Systems, Vol 11, Iss 2, Pp 66-71 (2010)
Externí odkaz:
https://doaj.org/article/c5a1727d19fd4637be58c4f119303a1c
Publikováno v:
Preventing Chronic Disease, Vol 3, Iss 1 (2005)
Externí odkaz:
https://doaj.org/article/f65528497b404ce4b0e35c27fd2baf26
Autor:
Kimball A Johnson, Nancy Martin, Rossella E Nappi, Genevieve Neal-Perry, Marla Shapiro, Petra Stute, Rebecca C Thurston, Wendy Wolfman, Marci English, Catherine Franklin, Misun Lee, Nanette Santoro
Publikováno v:
Johnson, Kimball A; Martin, Nancy; Nappi, Rossella E; Neal-Perry, Genevieve; Shapiro, Marla; Stute, Petra; Thurston, Rebecca C; Wolfman, Wendy; English, Marci; Franklin, Catherine; Lee, Misun; Santoro, Nanette (2023). Efficacy and Safety of Fezolinetant in Moderate-to-Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT. The Journal of clinical endocrinology and metabolism, 108(8), pp. 1981-1997. The Endocrine Society 10.1210/clinem/dgad058
ContextVasomotor symptoms (VMS) are common, bothersome, and can persist for years before and after menopause.ObjectiveWe aimed to assess efficacy/safety of fezolinetant for treatment of moderate to severe VMS associated with menopause.MethodsIn this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f73cb9b22c350ad2d8803512d46475e2
Autor:
Nancy Martin
Publikováno v:
The 23rd Annual Conference on Information Technology Education.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1bfb8f52024cde777dfcf33e69724a2b
https://doi.org/10.1145/3537674.3554745
https://doi.org/10.1145/3537674.3554745
Autor:
Nancy Martin
Publikováno v:
The 23rd Annual Conference on Information Technology Education.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75c3160df95a55a23ba9ddfd0a3aaaa8
https://doi.org/10.1145/3537674.3554746
https://doi.org/10.1145/3537674.3554746
Autor:
Srikanta Basu, Brian T. Luke, Baktiar Karim, Nancy Martin, Stephen Lockett, Sudipto Das, Thorkell Andresson, Karen Saylor, Serguei Kozlov, Laura Bassel, Dominic Esposito, Peter F. Johnson
Oncogenic RAS induces perinuclear translocation of the oncogenic kinases ERK1/2 and CK2 and the MAPK scaffold KSR1, forming endosomal signaling hubs termed perinuclear signaling centers (PSCs). PSCs are found in nearly all cancer cell lines and tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d04974a2c5b0edfba9f16a804f45cf9
https://doi.org/10.1101/2022.04.05.487175
https://doi.org/10.1101/2022.04.05.487175
Autor:
Linshan Hu, Sweta Misra, Baktiar Karim, Skyler Kuhn, Jacqueline Salotti, Srikanta Basu, Nancy Martin, Karen Saylor, Peter F. Johnson
The tumor suppressor p53 triggers senescence in response to oncogenic stress in primary cells. However, the mechanisms by which tumor cells retaining p53 bypass senescence are not fully understood. Here we report that p53 cytostatic activity is inhib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::145910cfa3fcadee068ac39e43dea46f
https://doi.org/10.1101/2022.04.04.487038
https://doi.org/10.1101/2022.04.04.487038
Autor:
Jacqueline Salotti, Baktiar Karim, Sweta Misra, Linshan Hu, Srikanta Basu, Nancy Martin, Brian T. Luke, Karen Saylor, Thorkell Andresson, David A. Scheiblin, Stephen Lockett, Lino Tessarollo, Peter F. Johnson
C/EBPβ is a potent regulator of RAS-induced senescence (RIS) and the SASP. C/EBPβ is post- translationally activated in RIS cells by the effector kinases ERK1/2 and CK2, but in tumor cells activation is suppressed by the CEBPB 3’UTR. 3′UTR regu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55ed09d3228d7898093bd7b9a2daf8a8
https://doi.org/10.1101/2022.03.29.486281
https://doi.org/10.1101/2022.03.29.486281